Episode 10: Part 3 of 3 What's New in the Treatment of Hemochromatosis? With Prof. Pierre Brissot
On June 17, 2020, the Canadian Hemochromatosis Society presented its first online information session in its Membership Lecture Series. We were honoured to have Prof. Pierre Brissot join us live from Rennes, France, to provide us with an updated view on the definition, diagnosis and treatment for hemochromatosis in 2020.Pierre Brissot is a Professor Emeritus of Medicine; Member of the French National Academy of Medicine; Past-President of the International BioIron Society; Founder or Co-founder of FFAMH (Fédération Française des Associations de Malades de l’Hémochromatose), EFAPH (European Federation of Associations of Patients with Haemochromatosis), and HI (Haemochromatosis International).In this third and final episode of the lecture, Prof. Brissot takes a closer look at mainstay and potential treatment options for hemochromatosis, and takes audience questions. To view the visuals Prof. Brissot references in this podcast, please visit https://www.toomuchiron.ca/video. We acknowledge the financial support of the Province of British Columbia in the production of this podcast. Support the show